PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 39 filers reported holding PREVAIL THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,819,000 | +2254.0% | 685,687 | +938.6% | 0.01% | +1000.0% |
| Q3 2020 | $672,000 | -64.7% | 66,022 | -48.3% | 0.00% | -66.7% |
| Q2 2020 | $1,904,000 | +61.5% | 127,811 | +32.2% | 0.00% | 0.0% |
| Q1 2020 | $1,179,000 | +90.8% | 96,687 | +92.1% | 0.00% | +200.0% |
| Q3 2019 | $618,000 | -74.0% | 50,338 | -72.1% | 0.00% | -75.0% |
| Q2 2019 | $2,379,000 | – | 180,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $140,713,000 | 1.77% |
| Omega Fund Management, LLC | 187,538 | $1,909,000 | 0.52% |
| Boxer Capital, LLC | 1,123,105 | $11,433,000 | 0.40% |
| RA Capital Management | 1,915,568 | $19,500,000 | 0.36% |
| DAFNA Capital Management LLC | 75,000 | $764,000 | 0.25% |
| QVT Financial LP | 133,690 | $1,361,000 | 0.17% |
| Woodline Partners LP | 385,480 | $3,924,000 | 0.13% |
| Virtus ETF Advisers LLC | 19,773 | $201,000 | 0.10% |
| WEXFORD CAPITAL LP | 37,963 | $386,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 53,018 | $540,000 | 0.09% |